For PRODUCT INFORMATION {Click Here}
News Room

Company News

December 2010
Business First - Small Company of the Year Finalist
US WorldMeds - Strategy of Pursuing Acquisitions Proves to be Healthy for Company

Sarah Jeffords Pister

August 2008
Avoiding Errors in the Reconstitution of Dantrolene Sodium for Injection During Malignant
Hyperthermia Episodes

Richard R. Morris, M.D., Ahmad Malkawi, Ph.D., Abeer A - Ghananeem, Ph.D., George A. Digenis, Ph.D.

Winter 2008
AAAASF Newsletter
| ASF SOURCE - (pg7)
US WorldMeds, a closely held Delaware limited liability company, introduces a generic equivalent to Dantrium® IV that is now available through wholesalers and GPOs.

July 2007
US WorldMeds receives FDA approval of its US marketing license (ANDA) for Dantrolene Sodium for Injection.
See the Orange Book (“Approved Drug Products with Therapeutic Equivalence Evaluations”). This product is AP rated.

December 2006
The Courier-Journal, US WorldMeds Chief Executive Officer shares vision for company.
Click here to review.

October 2006
US WorldMeds announces that it is enrolling study subjects in a Phase 3 clinical trial to determine the safety and efficacy of Lofexidine in relieving the debilitating withdrawal symptoms associated with opiate detoxification.
Click here to view.

August 2005
DSM Pharmaceuticals, Inc. and US WorldMeds, LLC announce signing of commercial supply agreement.
Click here to view.

January 2004
Visions Newsletter (see page 2).
Click here to view.

November 2003
Britannia signs agreement with US WorldMeds to bring first non-opiate drug addiction treatment to the US.
Click here for a copy of Britannia's press release. (29 KB)

June 2003
New study shows the potential of BritLofex™ in preventing opiate relapse.
Click here for a copy of Britannia's press release. (55 KB)

June 2002
Trial of Britannia Pharmaceuticals’ BritLofex™ stopped early due to overwhelming efficacy.
Click here for a copy of Britannia's press release. (47KB)

 

BritLofex is a trademark of Britannia Pharmaceuticals Ltd.
Dantrium is a registered trademark of JHP Pharmaceuticals, LLC.